High-density lipoproteins for therapeutic delivery systems

R Kannan Mutharasan, Linda Foit, C. Shad Thaxton*

*Corresponding author for this work

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

High-density lipoproteins (HDL) are a class of natural nanostructures found in the blood and are composed of lipids, proteins, and nucleic acids (e.g. microRNA). Their size, which appears to be well-suited for both tissue penetration/retention as well as payload delivery, long circulation half-life, avoidance of endosomal sequestration, and potential low toxicity are all excellent properties to model in a drug delivery vehicle. In this review, we consider high-density lipoproteins for therapeutic delivery systems. First we discuss the structure and function of natural HDL, describing in detail its biogenesis and transformation from immature, discoidal forms, to more mature, spherical forms. Next we consider features of HDL making them suitable vehicles for drug delivery. We then describe the use of natural HDL, discoidal HDL analogs, and spherical HDL analogs to deliver various classes of drugs, including small molecules, lipids, and oligonucleotides. We briefly consider the notion that the drug delivery vehicles themselves are therapeutic, constituting entities that exhibit "theralivery." Finally, we discuss challenges and future directions in the field.

Original languageEnglish (US)
Pages (from-to)188-197
Number of pages10
JournalJournal of Materials Chemistry B
Volume4
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Lipoproteins
HDL Lipoproteins
Drug delivery
Lipids
Oligonucleotides
Nucleic acids
MicroRNAs
Nucleic Acids
Toxicity
Nanostructures
Blood
Tissue
Proteins
Molecules
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Chemistry(all)
  • Biomedical Engineering
  • Materials Science(all)

Cite this

Mutharasan, R Kannan ; Foit, Linda ; Shad Thaxton, C. / High-density lipoproteins for therapeutic delivery systems. In: Journal of Materials Chemistry B. 2015 ; Vol. 4, No. 2. pp. 188-197.
@article{a937701f07fa429aab4440eff6d640ab,
title = "High-density lipoproteins for therapeutic delivery systems",
abstract = "High-density lipoproteins (HDL) are a class of natural nanostructures found in the blood and are composed of lipids, proteins, and nucleic acids (e.g. microRNA). Their size, which appears to be well-suited for both tissue penetration/retention as well as payload delivery, long circulation half-life, avoidance of endosomal sequestration, and potential low toxicity are all excellent properties to model in a drug delivery vehicle. In this review, we consider high-density lipoproteins for therapeutic delivery systems. First we discuss the structure and function of natural HDL, describing in detail its biogenesis and transformation from immature, discoidal forms, to more mature, spherical forms. Next we consider features of HDL making them suitable vehicles for drug delivery. We then describe the use of natural HDL, discoidal HDL analogs, and spherical HDL analogs to deliver various classes of drugs, including small molecules, lipids, and oligonucleotides. We briefly consider the notion that the drug delivery vehicles themselves are therapeutic, constituting entities that exhibit {"}theralivery.{"} Finally, we discuss challenges and future directions in the field.",
author = "Mutharasan, {R Kannan} and Linda Foit and {Shad Thaxton}, C.",
year = "2015",
month = "1",
day = "1",
doi = "10.1039/c5tb01332a",
language = "English (US)",
volume = "4",
pages = "188--197",
journal = "Journal of Materials Chemistry B",
issn = "2050-7518",
publisher = "Royal Society of Chemistry",
number = "2",

}

High-density lipoproteins for therapeutic delivery systems. / Mutharasan, R Kannan; Foit, Linda; Shad Thaxton, C.

In: Journal of Materials Chemistry B, Vol. 4, No. 2, 01.01.2015, p. 188-197.

Research output: Contribution to journalArticle

TY - JOUR

T1 - High-density lipoproteins for therapeutic delivery systems

AU - Mutharasan, R Kannan

AU - Foit, Linda

AU - Shad Thaxton, C.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - High-density lipoproteins (HDL) are a class of natural nanostructures found in the blood and are composed of lipids, proteins, and nucleic acids (e.g. microRNA). Their size, which appears to be well-suited for both tissue penetration/retention as well as payload delivery, long circulation half-life, avoidance of endosomal sequestration, and potential low toxicity are all excellent properties to model in a drug delivery vehicle. In this review, we consider high-density lipoproteins for therapeutic delivery systems. First we discuss the structure and function of natural HDL, describing in detail its biogenesis and transformation from immature, discoidal forms, to more mature, spherical forms. Next we consider features of HDL making them suitable vehicles for drug delivery. We then describe the use of natural HDL, discoidal HDL analogs, and spherical HDL analogs to deliver various classes of drugs, including small molecules, lipids, and oligonucleotides. We briefly consider the notion that the drug delivery vehicles themselves are therapeutic, constituting entities that exhibit "theralivery." Finally, we discuss challenges and future directions in the field.

AB - High-density lipoproteins (HDL) are a class of natural nanostructures found in the blood and are composed of lipids, proteins, and nucleic acids (e.g. microRNA). Their size, which appears to be well-suited for both tissue penetration/retention as well as payload delivery, long circulation half-life, avoidance of endosomal sequestration, and potential low toxicity are all excellent properties to model in a drug delivery vehicle. In this review, we consider high-density lipoproteins for therapeutic delivery systems. First we discuss the structure and function of natural HDL, describing in detail its biogenesis and transformation from immature, discoidal forms, to more mature, spherical forms. Next we consider features of HDL making them suitable vehicles for drug delivery. We then describe the use of natural HDL, discoidal HDL analogs, and spherical HDL analogs to deliver various classes of drugs, including small molecules, lipids, and oligonucleotides. We briefly consider the notion that the drug delivery vehicles themselves are therapeutic, constituting entities that exhibit "theralivery." Finally, we discuss challenges and future directions in the field.

UR - http://www.scopus.com/inward/record.url?scp=84952326597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952326597&partnerID=8YFLogxK

U2 - 10.1039/c5tb01332a

DO - 10.1039/c5tb01332a

M3 - Article

VL - 4

SP - 188

EP - 197

JO - Journal of Materials Chemistry B

JF - Journal of Materials Chemistry B

SN - 2050-7518

IS - 2

ER -